Diluted EPS came in at $-0.36 (-9.1% YoY).
Trailing eight quarters through Q1 2025
Common questions about XBiotech's Q1 2025 earnings report.
XBiotech (XBIT) reported Q1 2025 earnings on May 14, 2025 before market open.
XBiotech reported diluted EPS of $-0.36 for Q1 2025.
Compared to the same quarter a year prior, diluted EPS declined 9.1% from $-0.33.
You can read the 10-K/A periodic report (0001171843-25-002595) directly on SEC EDGAR. The filing index links above go to sec.gov.